![Katey Owen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 30/06/2026
Katey Owen is currently an Independent Director at Adaptive Biotechnologies Corp.
since 2021 and Director-Vaccine Development at Gates Foundation Trust since 2022.
Formerly, Dr. Owen was Senior Director at Merck & Co., Inc. Education includes undergraduate and doctorate degrees from Purdue University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/04/2026 | 72.629 ( 0,05 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Director/Miembro de la Junta | 17/03/2021 |
Gates Foundation Trust
 Gates Foundation Trust Financial ConglomeratesFinance Foundation | Corporate Officer/Principal | 01/08/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Gates Foundation Trust
Gates Foundation Trust Financial ConglomeratesFinance Foundation | Finance |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
